Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
about
Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of ActionTreatment of painful bladder syndrome/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients?Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA InjectionBotulinum toxin-what urologic uses does the data support?Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction.Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions.New intraprostatic injectables and prostatic urethral lift for male LUTS.Current and potential urological applications of botulinum toxin A.Benign Prostatic Hyperplasia: Review of Modern Minimally Invasive Surgical Treatments.Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes.Botulinum toxin and benign prostatic hyperplasia.
P2860
Q26750535-869A8131-D195-45E2-9683-64BB50A0C5FCQ26773579-BE0670FC-E4DA-4B5A-9985-963CEF75345CQ28087509-5C8A02C6-215D-48B1-AA70-D27C948625FEQ30620372-C9FC0F5C-DB50-42A2-8A49-AF4B84187014Q37707769-D2282B98-5297-4A50-B0D1-7FE5F81C59CCQ38262923-05ECF051-36E3-429F-BA0F-B1D7825CF706Q38551294-F5253961-5C6A-4A48-9A3B-E98DEF755F88Q38564108-4B140AEA-A172-4D52-AB03-FD095261B62EQ38943211-5A146127-4473-442A-94C4-E8E3410F31FDQ39163861-EB79489B-D236-4E55-92D2-44A1C76963C8Q47978895-03555907-C431-4B4B-9C54-3651BA5DFCCFQ55710256-8FF55AC6-9B4D-4D4D-9934-B2F218227686
P2860
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Patient-reported outcomes in m ...... ive single-armed cohort study.
@ast
Patient-reported outcomes in m ...... ive single-armed cohort study.
@en
Patient-reported outcomes in men with lower urinary tract symptoms
@nl
type
label
Patient-reported outcomes in m ...... ive single-armed cohort study.
@ast
Patient-reported outcomes in m ...... ive single-armed cohort study.
@en
Patient-reported outcomes in men with lower urinary tract symptoms
@nl
prefLabel
Patient-reported outcomes in m ...... ive single-armed cohort study.
@ast
Patient-reported outcomes in m ...... ive single-armed cohort study.
@en
Patient-reported outcomes in men with lower urinary tract symptoms
@nl
P2093
P2860
P1433
P1476
Patient-reported outcomes in m ...... tive single-armed cohort study
@en
P2093
Alessandro D'Addessi
Angelo Totaro
Francesco Marangi
Francesco Pinto
Marco Racioppi
Matteo Vittori
Pierfrancesco Bassi
Riccardo Bientinesi
P2860
P304
P356
10.1111/J.1464-410X.2012.11288.X
P433
P50
P577
2012-06-19T00:00:00Z